Drinking 3 Cups of Coffee Cuts Skin Cancer Risk

If you're spending time outdoors—whether hiking, gardening, or just walking to work—you’ve likely worried about sun exposure and skin cancer. While most people focus on sunscreen and protective clothing, recent research suggests your daily coffee habit might also offer some protection, specifically against the most common form of skin cancer.

The quick answer? Drinking three or more cups of caffeinated coffee per day may reduce your risk of developing basal cell carcinoma (BCC) by up to 20%—especially for women. That’s according to a major study presented at an international cancer conference backed by the American Cancer Research Association.

What Is Basal Cell Carcinoma?

Basal cell carcinoma (BCC) is the most frequently diagnosed type of skin cancer. It grows slowly and rarely spreads, but it still accounts for the majority of skin cancer cases globally. Unlike melanoma, which is aggressive and deadly, BCC is far more common but usually less dangerous—if caught early. It often appears as a shiny bump or sore that doesn’t heal on sun-exposed areas like the face, neck, or arms.

The Coffee and Skin Cancer Study

Researchers presented their findings at the Tenth International Conference on Frontiers in Cancer Prevention Research, hosted by the American Association for Cancer Research (AACR). The study specifically investigated whether coffee consumption had any link to the risk of three types of skin cancer: basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma.

The results were clear: coffee drinking was associated with a reduced risk of BCC only—not SCC or melanoma. This points to a specific effect linked to one type of skin cancer and not a general anti-cancer property of coffee.

How Much Coffee Makes a Difference?

The data showed a dose-response relationship: the more coffee people drank, the lower their risk of BCC. Specifically:

• Women who drank three or more cups of caffeinated coffee per day had a 20% lower risk of BCC compared to those who drank less than one cup per month.
• Men who drank the same amount saw a 9% reduction in risk.
• People who drank less than one cup per month served as the baseline group for comparison.

Importantly, these effects were observed only with caffeinated coffee. Decaffeinated coffee showed no significant reduction in BCC risk, suggesting that caffeine—or a compound closely tied to it—is likely responsible for the protective effect.

Why Caffeine Might Protect Against BCC

While the study did not pinpoint the exact mechanism, researchers hypothesize that caffeine plays a key role. Caffeine is known to influence cell behavior, including promoting the death of damaged skin cells—a process that could help prevent the abnormal growth seen in BCC.

The study’s lead researcher, Dr. Fengju Song, a postdoctoral fellow in dermatology at Harvard Medical School, emphasized that “our new studies indicate that drinking coffee is an important measure to prevent basal cell carcinoma.” The protective trend was consistent and dose-dependent, reinforcing the idea that regular coffee intake—particularly of the caffeinated kind—has a measurable impact on BCC risk.

Frequently Asked Questions

Does decaf coffee reduce skin cancer risk too?

No. The study found that only caffeinated coffee was associated with a reduced risk of basal cell carcinoma. Decaffeinated coffee showed no significant protective effect.

What types of skin cancer did the study look at?

The research examined three types: basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. The protective effect was observed only with BCC.

How many cups of coffee are needed to see a benefit?

People who drank three or more cups of caffeinated coffee per day had the lowest risk. Women in that group saw a 20% reduction in BCC risk, while men saw a 9% drop.

Does drinking coffee protect against melanoma or squamous cell carcinoma?

No. The study found no evidence that coffee consumption lowers the risk of melanoma or squamous cell carcinoma—only basal cell carcinoma.

Is caffeine the only protective compound in coffee?

Probably. Since decaf coffee didn’t show the same benefits, researchers believe caffeine—or something closely linked to it—is likely the active agent reducing BCC risk.